2 not yet recruiting, 1 completed. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Not yet recruiting 2, Completed 1 |
Follow Galactose: new trials by email Literature Review of Galactose trials Research Report on Galactose
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| AVTX-801 D-galactose Supplementation in SLC35A2-CDG AVTX-801, Placebo - SLC35A2-CDG - Solute Carrier Family 35 Member A2 Congenital Disorder of Glycosylation | Phase 2 | Not yet recruiting | Eva Morava-Kozicz | 10 | 2027-01-01 | 2026-06-29 |
| Evaluating the Efficacy and Safety of D-galactose in PGM1-CDG (AVTX-801) AVTX-801, Placebo - PGM1-CDG - Phosphoglucomutase 1-Related Congenital Disorder of Glycosylation | Phase 2 | Not yet recruiting | Eva Morava-Kozicz | 8 | 2026-10-01 | 2026-03-16 |
| Novel Therapies for Resistant FSGS (FONTII): Phase II Clinical Trial Adalimumab, Lisinopril, losartan, and atorvastatin, galactose - Focal Segmental Glomerulosclerosis | Phase 2 | Completed | NYU Langone Health | 32 | 2008-12-01 | 2016-07-11 |
Glomerulosclerosis, Focal Segmental (1) · Glycogen Storage Disease XIV (1)
Eva Morava-Kozicz (2) · NYU Langone Health (1)
United States (3) · Canada (1)
Eva Morava-Kozicz, MD, PhD (2) · Debbie Gipson, MD (1) · Howard Trachtman, MD (1) · Jennifer Gassman, PhD (1)
PMID 19073787, PMID 19932542, PMID 21310077, PMID 26198842, PMID 35224732, PMID 40337980
R33DK070341 (1), U54NS115198 (1)